IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MACCHI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.975
AS - Asia 8.771
NA - Nord America 8.503
SA - Sud America 743
AF - Africa 202
OC - Oceania 123
Continente sconosciuto - Info sul continente non disponibili 7
Totale 28.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.033
CN - Cina 3.331
IT - Italia 2.562
DE - Germania 2.295
GB - Regno Unito 2.203
SG - Singapore 1.938
HK - Hong Kong 678
RU - Federazione Russa 542
BR - Brasile 529
SE - Svezia 518
BD - Bangladesh 511
FR - Francia 389
VN - Vietnam 386
IN - India 372
JP - Giappone 312
CA - Canada 278
NL - Olanda 247
KR - Corea 216
ID - Indonesia 201
TR - Turchia 185
IE - Irlanda 170
ES - Italia 168
FI - Finlandia 168
MX - Messico 132
TW - Taiwan 128
DK - Danimarca 114
AU - Australia 112
IR - Iran 80
PL - Polonia 78
UA - Ucraina 77
BE - Belgio 63
AT - Austria 62
AR - Argentina 61
RO - Romania 55
AE - Emirati Arabi Uniti 53
PH - Filippine 48
TH - Thailandia 45
CH - Svizzera 44
EG - Egitto 44
CL - Cile 42
MY - Malesia 41
ZA - Sudafrica 41
CI - Costa d'Avorio 34
PK - Pakistan 32
PT - Portogallo 32
IL - Israele 31
IQ - Iraq 31
CO - Colombia 28
SA - Arabia Saudita 28
GR - Grecia 27
HR - Croazia 24
EC - Ecuador 23
RS - Serbia 22
HU - Ungheria 21
PE - Perù 20
SI - Slovenia 20
VE - Venezuela 19
LB - Libano 18
JO - Giordania 17
PS - Palestinian Territory 16
TN - Tunisia 14
UZ - Uzbekistan 13
CR - Costa Rica 12
MA - Marocco 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
NZ - Nuova Zelanda 11
HN - Honduras 9
JM - Giamaica 9
NG - Nigeria 9
NP - Nepal 9
RE - Reunion 9
BO - Bolivia 8
DZ - Algeria 8
LT - Lituania 8
PY - Paraguay 8
SC - Seychelles 8
BG - Bulgaria 7
SK - Slovacchia (Repubblica Slovacca) 7
EE - Estonia 6
IS - Islanda 6
NO - Norvegia 6
SV - El Salvador 6
AL - Albania 5
AM - Armenia 5
CU - Cuba 5
LV - Lettonia 5
LK - Sri Lanka 4
OM - Oman 4
PR - Porto Rico 4
QA - Qatar 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BJ - Benin 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
KE - Kenya 3
Totale 28.266
Salva come PNG Salva come JPEG
Città #
Southend 1.906
Hanover 1.360
Singapore 1.145
Ashburn 833
Milan 818
Hong Kong 558
Dallas 486
San Jose 480
Beijing 443
Chandler 438
Frankfurt am Main 361
Fairfield 330
Council Bluffs 289
Wilmington 275
Redwood City 254
Los Angeles 253
Seattle 228
Shanghai 219
Guangzhou 208
New York 188
Nanjing 172
Houston 168
Woodbridge 168
Dublin 160
Ann Arbor 159
Hefei 156
Princeton 154
Santa Clara 154
Dearborn 141
Cambridge 136
Rome 133
Jakarta 117
Ho Chi Minh City 112
The Dalles 106
Istanbul 103
Hanoi 99
Lauterbourg 98
Bengaluru 96
Tokyo 92
Toronto 91
Boardman 89
Moscow 86
Berlin 85
Changsha 84
Taipei 81
Buffalo 79
Helsinki 79
Munich 76
Des Moines 69
Seoul 67
Wuhan 65
Grafing 62
Jinan 59
Phoenix 57
Tianjin 56
Hangzhou 50
Columbus 49
Shenyang 47
Chengdu 46
Zhengzhou 46
São Paulo 45
Chicago 44
Montreal 43
Atlanta 39
Bologna 39
Al Ain City 38
Cangzhou 36
San Diego 35
Shenzhen 34
Vienna 34
Abidjan 33
Paris 33
Nuremberg 32
Mountain View 31
Washington 31
Genoa 30
Hebei 30
London 30
Mumbai 30
Naples 30
Padova 30
Turin 30
Lappeenranta 29
Brussels 27
Amsterdam 26
Magenta 26
Orem 26
Santiago 26
Central 25
Jiaxing 25
Johannesburg 25
Chongqing 24
Sunnyvale 24
Bari 23
Kuala Lumpur 23
Sydney 23
Falls Church 22
Florence 22
Ottawa 22
Roxbury 22
Totale 16.216
Salva come PNG Salva come JPEG
Nome #
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor 2.507
Effect of soy on metabolic syndrome and cardiovascular risk factors : a randomized controlled trial 1.789
Suppressor of Cytokine Signaling-3 (SOCS-3) induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line 637
Osteocalcin as a potential risk biomarker for cardiovascular and metabolic diseases 619
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels - experimental and clinical approaches with lipid-lowering agents 588
Body composition and metabolic changes during a 520-day mission simulation to Mars 543
Lipid Lowering Drugs and Inflammatory Changes: an Impact on Cardiovascular Outcomes? 519
Unsaponifiable fraction of unripe fruits of Olea europaea : An interesting source of anti-inflammatory constituents 514
Leptin, Resistin, and Proprotein Convertase Subtilisin/Kexin Type 9: The Role of STAT3 512
A new dawn for managing dyslipidemias: The era of rna-based therapies 462
DEVELOPMENT AND PATHOPHYSIOLOGICAL CHARACTERIZATION OF AN IN VIVO MODEL OF IRON OVERLOAD ASSOCIATED TO INSULIN RESISTANCE AND REPRODUCTIVE IMPAIRMENT 445
Cyclase-associated protein 2 (CAP2) controls MRTF-A localization and SRF activity in mouse embryonic fibroblasts 418
PCSK9 induces a pro-inflammatory response in macrophages 416
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor 401
Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake 398
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract : results from a randomized, double-blind, placebo-controlled study 396
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation 393
Serological follow-up of SARS-CoV-2 asymptomatic subjects 386
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models 375
Cholesteryl ester transfer protein: An enigmatic pharmacology – Antagonists and agonists 373
Selective and active targeting of neuropeptide Y receptors in experimental oncology: use of gold nanocages conjugated to short peptides 357
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 318
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor 304
Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals 300
Maternal exposure to air pollutants, PCSK9 levels, fetal growth and gestational age – An Italian cohort 293
Valutazione dei benefici salutistici dell'assunzione dI proteine della soia in pazienti con moderata sindrome metabolica 290
PCSK9 Expression in Epicardial Adipose Tissue : Molecular Association with Local Tissue Inflammation 288
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 283
Sex-specific predictors of PCSK9 levels in a European population : the IMPROVE study 275
Iron overload impairs the migratory ability of a model of immature and migratory GnRH neurons 273
Liver fat accumulation is associated with circulating PCSK9 levels 272
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity 267
Evaluation of the health benefits of soy protein consumption in patients carrying the metabolic syndrome 260
Nutraceutical approach to moderate cardiometabolic risk : results of a randomized, double-blind and crossover study with Armolipid Plus 251
Relationship between circulating PCSK9 and markers of subclinical atherosclerosis—the improve study 244
Increased circulating adiponectin in males with chronic HCV hepatitis 242
BDNF Val66Met polymorphism alters food intake and hypothalamic BDNF expression in mice 242
Statin therapy and related risk of new-onset type 2 diabetes mellitus 239
Pro-inflammatory cytokines and adipokines regulate PCSK9 expression in HepG2 cells 234
SOCS-3 induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic HepG2 cell line: a potential link between hypertriglyceridemia and insulin resistance 232
Brain-Derived Neurotrophic Factor and Extracellular Vesicle-Derived miRNAs in an Italian Cohort of Individuals With Obesity: A Key to Explain the Link Between Depression and Atherothrombosis 230
Gold nanocages for imaging and therapy of prostate cancer cells 229
Impact Of Iron Overload On Reproductive Axis Impairment: Pathophysiological Insights From In Vitro And In Vivo Studies 228
Liver fat accumulation is associated with circulating PCSK9 227
Monocarboxylate transporter 1 deficiency impacts CD8+ T lymphocytes proliferation and recruitment to adipose tissue during obesity 225
An association study of cyclase-associated protein 2 and frailty 225
SOCS-3 induces PCSK9 expression in hepatic HepG2 cell line 224
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance 223
Exploring the role of epicardial adipose-tissue-derived extracellular vesicles in cardiovascular diseases 222
Reduction of cardio-metabolic risk and body weight through a multiphasic very-low calorie ketogenic diet program in women with overweight/obesity: A study in a real-world setting 220
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance 219
PCSK9 expression is regulated by pro-inflammatory cytokines and adipokines in HEPG2 cells 215
STAT3 inhibition induces PCSK9 in hepatic cell line: possible involvement in hypertriglyceridemia associated with insulin resistance 212
STAT3 inhibition induces PCSK9 in hepatic cell line: possible involvement in hypertriglyceridemia associated with insulin resistance 211
Adipose tissue related adipokines and cytokines regulate PCSK9 expression in HepG2 cells 211
IRON OVERLOAD IMPAIRS THE MIGRATORY PROPERTIES OF IMMATURE GNRH NEURONS IN VITRO 210
Characterization and sub-cellular localization of somatostatin receptors in DU-145 and PC-3 human androgen-independent prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth 201
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease 199
Suppressor of cytokine signaling-3 (SOCS-3) induces proprotein convertase subtilisin kexin type 9 (PCSK9) expression in hepatic hepg2 cell line 196
Impact of Atorvastatin on Skeletal Muscle Mitochondrial Activity, Locomotion and Axonal Excitability-Evidence from ApoE-/- Mice 195
Prognostic parameters of in‐hospital mortality in COVID‐19 patients—An Italian experience 190
PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells 189
Iron overload induces hypogonadism in male mice via extrahypothalamic mechanisms 188
Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells 186
Proprotein convertase subtilisin kexin type 9 and high-density lipoprotein metabolism : experimental animal models and clinical evidence 184
SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms 184
PCSK9, SINDROME METABOLICA E DIABETE 182
Characterization of replicative and doxorubicin-induced senescence models in vascular smooth muscle cells 181
Lentilactobacillus kefiri SGL 13 and Andrographis paniculata alleviate dextran sulfate sodium induced colitis in mice 178
HDL in COVID-19 Patients: Evidence from an Italian Cross-Sectional Study 177
Mitochondrial function in patients affected with fibromyalgia syndrome is impaired and correlates with disease severity 175
Circulating PCSK9 as a prognostic biomarker of cardiovascular events in individuals with type 2 diabetes: evidence from a 16.8-year follow-up study 172
Indoor air pollution impacts cardiovascular autonomic control during sleep and the inflammatory profile 171
Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients 171
The role of extracellular vesicle-derived miRNA in the atherosclerotic burden 170
Anticancer Activity of Delta-Tocotrienol in Human Hepatocarcinoma: Involvement of Autophagy Induction 167
Extracellular vesicles in cardiomyopathies: A narrative review 164
TNF-alpha induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) expression in hepatic HepG2 cell line in a SOCS-3-dependent manner 163
Selective ERbeta activation leads to somatostatin receptor up-regulation in prostate cancer cells 158
PGC1-α-driven mitochondrial biogenesis contributes to a cancer stem cell phenotype in melanoma 157
Risk identification and possible countermeasures for muscle adverse effects during statin therapy 157
Pollution from fine particulate matter and atherosclerosis: A narrative review 156
SIMVASTATIN AMELIORATES SENESCENCE-INDUCED MITOCHONDRIAL DYSFUNCTION IN VASCULAR SMOOTH MUSCLE CELLS 155
Vescicole extracellulari nel contesto dell'aterosclerosi = Extracellular vesicles in atherothrombosis 154
Free and bound plasma leptin in anorexia nervosa patients during a refeeding program 149
L’attivazione selettiva di ERbeta in cellule di carcinoma prostatico promuove una iper-espressione dei recettori di somatostatina 148
Appropriateness of statin prescription in the elderly 145
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending? 143
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study 136
Serum Irisin levels and metabolic state in amyotrophic lateral sclerosis 135
Protocol to evaluate the impact of murine MCT1-deficient CD8+ T cells on adipogenesis 134
Inhibition of ATP citrate lyase does not affect muscle mitochondrial activity in apoE-/- mice 133
Proprotein Convertase Subtilisin/Kexin Type 9: A View beyond the Canonical Cholesterol-Lowering Impact 129
Proteomics and Lipidomics to unveil the contribution of PCSK9 beyond cholesterol lowering: a narrative review 129
Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status 129
Lipoprotein(a) and the atherosclerotic burden – Should we wait for clinical trial evidence before taking action? 128
SGLT2 Inhibitor Canagliflozin Triggers Hepatic Transcriptional Reprogramming and Impacts Systemic Metabolism in Mice with Diet-Induced Obesity 123
Cardiometabolic risk factors in adults with cystic fibrosis undergoing elexacaftor/tezacaftor/ivacaftor therapy 116
The role of the PPAR system in diabetic cardiovascular risk and beyond 116
Impact of Phyllantus niruri and Lactobacillus amylovorus SGL 14 in a mouse model of dietary hyperoxaluria 116
Totale 28.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 0 171
2021/20223.675 211 191 215 374 371 357 327 335 409 299 245 341
2022/20232.158 208 216 210 193 210 308 106 157 217 67 138 128
2023/20242.437 121 151 195 309 425 229 124 177 108 137 183 278
2024/20254.231 194 284 191 377 313 222 246 468 280 453 480 723
2025/20268.565 761 579 1.033 617 722 561 990 389 807 620 1.013 473
Totale 29.323